HB6227 - Adding Coccidioidomycosis to the FDA Priority Review Voucher Program Act of 2023
US Congress - 118th Congress
Introduced byDavid Schweikert, Kevin McCarthy, Michael C. Burgess
Last updated 11 months ago
36 Co-Sponsors
To amend the Federal Food, Drug, and Cosmetic Act to expand the tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis.
STATUS
Introduced
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now